Aanjaneya Lifesciences

Aanjaneya Lifesciences was an Indian pharmaceutical company specializing in the manufacture of Active Pharmaceutical Ingredients (APIs) and finished dosage forms. The company was notably one of the world's largest producers of Quinine salts and focused heavily on anti-malarial treatments. It operated manufacturing facilities in Mahad and Tarapur, India, and offered a range of products across therapeutic areas including oncology and cardiovascular health. At its peak, the company was publicly traded on the Bombay Stock Exchange and National Stock Exchange of India. However, the company faced severe financial distress and legal challenges, leading to its delisting and liquidation. Its assets were eventually acquired by financial creditors following insolvency proceedings.